In HCC, the influence of immune checkpoints on the prognosis of patients is extensive and complex; increased expression of PD-1, PD-L1, and tumor-infiltrating lymphocytes in HCC induces immunosuppression [42]. This evidence concerns the gene PDCD1 and hepatocellular carcinoma.